Literature DB >> 20056648

Patterns of sex steroid hormones in nipple aspirate fluid during the menstrual cycle and after menopause in relation to serum concentrations.

Robert T Chatterton1, Seema A Khan, Richard Heinz, David Ivancic, Oukseub Lee.   

Abstract

Previous studies have shown that progesterone concentrations in serum and nipple aspirate fluid (NAF) are significantly correlated in premenopausal women, but estradiol concentrations are not. We therefore sought to ascertain the patterns of both steroids in NAF throughout the menstrual cycle and in postmenopausal women. Simultaneous samples of blood and NAF were obtained from 40 premenopausal and 16 postmenopausal women. Premenopausal samples were backdated from the following menstrual period. Steroids were purified by high-performance liquid chromatography before quantification by immunoassays. Serum steroids and NAF progesterone followed the expected pattern across the menstrual cycle, with a midcycle peak of estradiol and a midluteal peak of progesterone. However, the estradiol peak in NAF occurred about a week after the serum peak in the midluteal phase, when serum estradiol had declined to less than half the value at midcycle. NAF estrone was also elevated at the midluteal phase. Potential estrogen precursors androstenedione, estrone sulfate, and dehydroepiandrosterone sulfate declined in NAF from midcycle to the midluteal phase as NAF estradiol was increasing. Progesterone concentrations were significantly lower in NAF in postmenopausal women than in premenopausal women, but estrogen concentrations were not. This is the first description of the temporal relationships of sex steroids in NAF and serum relative to the menstrual cycle. These results provide insights into the lack of correlation of NAF and breast tissue estrogens with serum estrogens, and generate new hypotheses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20056648     DOI: 10.1158/1055-9965.EPI-09-0381

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  10 in total

1.  Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.

Authors:  Seema A Khan; Robert T Chatterton; Nancy Michel; Michelle Bryk; Oukseub Lee; David Ivancic; Richard Heinz; Carola M Zalles; Irene B Helenowski; Borko D Jovanovic; Adrian A Franke; Maarten C Bosland; Jun Wang; Nora M Hansen; Kevin P Bethke; Alexander Dew; Margerie Coomes; Raymond C Bergan
Journal:  Cancer Prev Res (Phila)       Date:  2012-02

2.  Nipple Aspirate Fluid Hormone Concentrations and Breast Cancer Risk.

Authors:  Robert T Chatterton; Richard E Heinz; Angela J Fought; David Ivancic; Claire Shappell; Subhashini Allu; Susan Gapstur; Denise M Scholtens; Peter H Gann; Seema A Khan
Journal:  Horm Cancer       Date:  2016-02-22       Impact factor: 3.869

3.  A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast.

Authors:  Oukseub Lee; Katherine Page; David Ivancic; Irene Helenowski; Vamsi Parini; Megan E Sullivan; Julie A Margenthaler; Robert T Chatterton; Borko Jovanovic; Barbara K Dunn; Brandy M Heckman-Stoddard; Kathleen Foster; Miguel Muzzio; Julia Shklovskaya; Silvia Skripkauskas; Piotr Kulesza; David Green; Nora M Hansen; Kevin P Bethke; Jacqueline S Jeruss; Raymond Bergan; Seema A Khan
Journal:  Clin Cancer Res       Date:  2014-07-15       Impact factor: 12.531

4.  Influence of diet on nipple aspirate fluid production and estrogen levels.

Authors:  Yukiko Morimoto; Shannon M Conroy; Ian S Pagano; Adrian A Franke; Frank Z Stanczyk; Gertraud Maskarinec
Journal:  Food Funct       Date:  2011-10-10       Impact factor: 5.396

5.  Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers.

Authors:  Jennifer T Loud; Gretchen L Gierach; Timothy D Veenstra; Roni T Falk; Kathryn Nichols; Allison Guttmann; Xia Xu; Mark H Greene; Mitchell H Gail
Journal:  Breast Cancer Res Treat       Date:  2014-01-18       Impact factor: 4.872

6.  Estrogen levels in nipple aspirate fluid and serum during a randomized soy trial.

Authors:  Gertraud Maskarinec; Nicholas J Ollberding; Shannon M Conroy; Yukiko Morimoto; Ian S Pagano; Adrian A Franke; Elisabet Gentzschein; Frank Z Stanczyk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-08       Impact factor: 4.254

7.  Protein Biomarkers for Breast Cancer Risk Are Specifically Correlated with Local Steroid Hormones in Nipple Aspirate Fluid.

Authors:  Ali Shidfar; Tolulope Fatokun; David Ivancic; Robert T Chatterton; Seema A Khan; Jun Wang
Journal:  Horm Cancer       Date:  2016-04-19       Impact factor: 3.869

8.  Expression of epidermal growth factor, transforming growth factor-β1 and adiponectin in nipple aspirate fluid and plasma of pre and post-menopausal women.

Authors:  Jessica A Miller; Patricia A Thompson; Iman A Hakim; Ana Maria Lopez; Cynthia A Thomson; Chiu-Hsieh Hsu; H-H Sherry Chow
Journal:  Biomark Res       Date:  2013-04-15

9.  Weight loss reduces breast ductal fluid estrogens in obese postmenopausal women: a single arm intervention pilot study.

Authors:  Catherine L Carpenter; Karen Duvall; Patricia Jardack; Luyi Li; Susanne M Henning; Zhaoping Li; David Heber
Journal:  Nutr J       Date:  2012-12-05       Impact factor: 3.271

10.  DNA promoter hypermethylation in nipple fluid: a potential tool for early breast cancer detection.

Authors:  Jolien S de Groot; Cathy B Moelans; Sjoerd G Elias; Mary Jo Fackler; Robert van Domselaar; Karijn P M Suijkerbuijk; Arjen J Witkamp; Saraswati Sukumar; Paul J van Diest; Elsken van der Wall
Journal:  Oncotarget       Date:  2016-04-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.